Cargando…
A multicentric pharmacovigilance study: collection and analysis of adverse drug reactions in relapsing-remitting multiple sclerosis patients
PURPOSE: We performed a pharmacovigilance study of 10 drugs used in patients with relapsing-remitting multiple sclerosis (RR-MS). Our aim was to provide an overview of the safety of these drugs by the evaluation of reported expected and unexpected adverse reactions. PATIENTS AND METHODS: We collecte...
Autores principales: | Gugliandolo, Agnese, Longo, Federica, Marrosu, Maria Giovanna, Mancardi, Giovanni Luigi, Gandoglia, Ilaria, Melis, Maurizio, Lo Giudice, Fabrizio, Bramanti, Placido, Mazzon, Emanuela |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6165854/ https://www.ncbi.nlm.nih.gov/pubmed/30310286 http://dx.doi.org/10.2147/TCRM.S174864 |
Ejemplares similares
-
Comparison of efficacy and safety of oral agents for the treatment of relapsing–remitting multiple sclerosis
por: Guarnera, Cristina, et al.
Publicado: (2017) -
Alemtuzumab: a review of efficacy and risks in the treatment of relapsing remitting multiple sclerosis
por: Guarnera, Cristina, et al.
Publicado: (2017) -
Role of Vitamin E in the Treatment of Alzheimer’s Disease: Evidence from Animal Models
por: Gugliandolo, Agnese, et al.
Publicado: (2017) -
Mesenchymal Stem Cells: A Potential Therapeutic Approach for Amyotrophic Lateral Sclerosis?
por: Gugliandolo, Agnese, et al.
Publicado: (2019) -
Activation of Nrf2 by Natural Bioactive Compounds: A Promising Approach for Stroke?
por: Gugliandolo, Agnese, et al.
Publicado: (2020)